Immunic Inc (IMUX): IMUX............................https://...

Replies (1) Next 10 Prev Next

glenn1919

Send PM Follow Ignore

Followers	309
Posts	57145
Boards Moderated	1
Alias Born	12/05/2003

glenn1919

Re: glenn1919 post# 150

Friday, 09/20/2024 8:42:38 AM

Friday, September 20, 2024 8:42:38 AM

IMUX............................https://stockcharts.com/h-sc/ui?s=IMUX&p=W&b=5&g=0&id=p86431144783

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IMUX News

Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 11:00:48 AM
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors • PR Newswire (US) • 05/19/2026 10:30:00 AM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:34:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:01:04 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 10:36:56 AM
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2026 10:30:00 AM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/06/2026 10:01:51 PM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 04/30/2026 09:15:46 PM
Immunic to Participate in Investor and Medical Conferences in May • PR Newswire (US) • 04/30/2026 10:30:00 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/29/2026 11:12:20 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:00:28 AM
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer • PR Newswire (US) • 04/28/2026 10:30:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 12:30:43 PM
Immunic, Inc. Announces 1-for-10 Reverse Stock Split • PR Newswire (US) • 04/23/2026 12:00:00 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/22/2026 08:56:18 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/17/2026 02:13:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:05:25 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/09/2026 08:30:55 PM
Immunic to Participate in Scientific and Medical Conferences in April • PR Newswire (US) • 04/09/2026 10:30:00 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2026 08:31:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 11:00:32 AM
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement • PR Newswire (US) • 04/01/2026 10:30:00 AM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent IMUX News

More IMUX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent IMUX News

Go Ad-Free